Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?

Checkpoint Inhibitors ◽

Meta Analysis ◽

Clinical Activity ◽

Reply to Xiaoshuai Gao, Guo Chen, and Xin Wei’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783–92

European Urology ◽

10.1016/j.eururo.2021.09.013 ◽

2021 ◽

Author(s):

Keiichiro Mori ◽

Manuela Schmidinger ◽

Shin Egawa ◽

Kilian M. Gust ◽

Shahrokh F. Shariat

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783–92

European Urology ◽

10.1016/j.eururo.2021.09.012 ◽

2021 ◽

Author(s):

Xiaoshuai Gao ◽

Guo Chen ◽

Xin Wei

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis

European Urology ◽

10.1016/j.eururo.2020.10.006 ◽

2020 ◽

Author(s):

Keiichiro Mori ◽

Mohammad Abufaraj ◽

Hadi Mostafaei ◽

Fahad Quhal ◽

Harun Fajkovic ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006

European Urology ◽

10.1016/j.eururo.2021.01.013 ◽

2021 ◽

Author(s):

Johanna Noel ◽

Olivier Huillard ◽

Francois Goldwasser

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis

Frontiers in Oncology ◽

10.3389/fonc.2019.01161 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 21

Author(s):

Yongfeng Wu ◽

Jinming Xu ◽

Chengli Du ◽

Yihua Wu ◽

Dajing Xia ◽

...

Keyword(s):

Systematic Review ◽

Immune Checkpoint ◽

Predictive Value ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Tumor Mutation Burden ◽

Mutation Burden

First-Line Treatments for Advanced Renal-Cell Carcinoma with Immune Checkpoint Inhibitors: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis

SSRN Electronic Journal ◽

10.2139/ssrn.3391198 ◽

2019 ◽

Author(s):

Yongrui Bai ◽

Jie Fu ◽

Yuchen Liu ◽

Jiangyang Du ◽

Qiang Zhang ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cost Effectiveness ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

First Line ◽

Effectiveness Analysis

BPI20-012: Relative Risk of Various Endocrinopathies Associated With the Use of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Renal Cell Carcinoma: a Systematic Review and Meta-Analysis

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2019.7448 ◽

2020 ◽

Vol 18 (3.5) ◽

pp. BPI20-012

Author(s):

Nusrat Jahan ◽

Francis Mogollon-Duffo ◽

Miguel Quirch ◽

Somedeb Ball ◽

Fred Hardwicke ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Relative Risk ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Line Treatment ◽

First Line ◽

First Line Treatment

The Predictive Value of blood-based tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Solid Cancers: A Systematic Review and Meta-Analysis

10.37766/inplasy2021.1.0115 ◽

2021 ◽

Author(s):

He Ba ◽

Jie Chen ◽

Yaodong Zhu

Keyword(s):

Systematic Review ◽

Immune Checkpoint ◽

Predictive Value ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Tumor Mutation Burden ◽

Mutation Burden

A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors

Endocrine Abstracts ◽

10.1530/endoabs.56.gp211 ◽

2018 ◽

Author(s):

Filette Jeroen de ◽

Corina Andreescu ◽

Filip Cools ◽

Bert Bravenboer ◽

Brigitte Velkeniers

Keyword(s):

Systematic Review ◽

Adverse Events ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis

Outcome of patients with advanced upper tract urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2021.103241 ◽

2021 ◽

Vol 159 ◽

pp. 103241

Author(s):

Melissa Bersanelli ◽

Sebastiano Buti ◽

Patrizia Giannatempo ◽

Daniele Raggi ◽

Andrea Necchi ◽

...

Keyword(s):

Systematic Review ◽

Urothelial Carcinoma ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Upper Tract Urothelial Carcinoma ◽

Upper Tract